aluates Reports

$ 0.0

Automative

Global Gastrointestinal Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030

Published Date: May 2024

Report Code: QYRE-Auto-3O396

Global Gastrointestinal Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Gastrointestinal Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030

Code: QYRE-Auto-3O396

Report

May 2024

Pages:152

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

AstraZenec

Sanofi

Bayer

Pfizer Inc

Zeria（Tillotts）

Perrigo

Boehringer Ingelheim

Purdue Pharma

C.B. Fleet

Abbott

Jiangzhong

Xian Janssen

GlaxoSmithKline

GlaxoSmithKline PLC

TEVA

Gastrointestinal Market Size

The global market for Gastrointestinal was estimated to be worth US$ 34710 million in 2023 and is forecast to a readjusted size of US$ 43730 million by 2030 with a CAGR of 3.3% during the forecast period 2024-2030.

Gastrointestinal Market

Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.

Global Gastrointestinal key players include AstraZeneca, Sanofi, Bayer, Pfizer, GlaxoSmithKline, etc. Global top five manufacturers hold a share over 25%.

Europe is the largest market, with a share about 45%, followed by Asia, and North America, both have a share over 45 percent.

In terms of product, Prescription Gastrointestinal Drug is the largest segment, with a share over 80%. And in terms of application, the largest application is Chronic Gastritis, followed by Peptic Ulcer, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gastrointestinal, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Gastrointestinal.

The Gastrointestinal market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gastrointestinal market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gastrointestinal companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Market Segmentation

Scope of Gastrointestinal Market Report

Report Metric	Details
Report Name	Gastrointestinal Market
Forecasted market size in 2030	US$ 43730 million
CAGR	3.3%
Forecasted years	2024 - 2030
Segment by Type	Prescription Gastrointestinal Drug OTC Gastrointestinal Drug
Segment by Application	Chronic Gastritis Functional Dyspepsia Peptic Ulcer Acute Gastroenteritis Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AstraZenec, Sanofi, Bayer, Pfizer, GlaxoSmithKline, Teva, Zeria（Tillotts）, Perrigo, Boehringer Ingelheim, Purdue Pharma, C.B. Fleet, Abbott, Jiangzhong, Xian-Janssen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Gastrointestinal in global and regional level.
Chapter 3: Detailed analysis of Gastrointestinal company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gastrointestinal revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion

FAQ for this report

What is the Gastrointestinal Market size in 2030?

Ans: The Gastrointestinal Market size in 2030 will be US$ 43730 million.

What is the market share of major companies in Gastrointestinal Market?

Ans: Global top five manufacturers hold a share over 25%.

What is the Gastrointestinal Market share by type?

Ans: In terms of product, Prescription Gastrointestinal Drug is the largest segment, with a share over 80%.

Who are the main players in the Gastrointestinal Market report?

Ans: The main players in the Gastrointestinal Market are AstraZenec, Sanofi, Bayer, Pfizer, GlaxoSmithKline, Teva, Zeria（Tillotts）, Perrigo, Boehringer Ingelheim, Purdue Pharma, C.B. Fleet, Abbott, Jiangzhong, Xian-Janssen

What are the Application segmentation covered in the Gastrointestinal Market report?

Ans: The Applications covered in the Gastrointestinal Market report are Chronic Gastritis, Functional Dyspepsia, Peptic Ulcer, Acute Gastroenteritis, Others

What are the Type segmentation covered in the Gastrointestinal Market report?

Ans: The Types covered in the Gastrointestinal Market report are Prescription Gastrointestinal Drug, OTC Gastrointestinal Drug

1 Study Coverage

1.1 Gastrointestinal Product Introduction

1.2 Market by Type

1.2.1 Global Gastrointestinal Market Size Growth Rate by Type (2019 VS 2023 VS 2030)

1.2.2 Prescription Gastrointestinal Drug

1.2.3 OTC Gastrointestinal Drug

1.3 Market by Application

1.3.1 Global Gastrointestinal Market Size Growth Rate by Application (2019 VS 2023 VS 2030)

1.3.2 Chronic Gastritis

1.3.3 Functional Dyspepsia

1.3.4 Peptic Ulcer

1.3.5 Acute Gastroenteritis

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Gastrointestinal Market Size Estimates and Forecasts

2.2 Gastrointestinal Market Size by Region: 2023 Versus 2030

2.2.1 Global Gastrointestinal Revenue by Region: 2019-2024

2.2.2 Global Gastrointestinal Revenue Forecast by Region (2025-2030)

2.2.3 Global Gastrointestinal Revenue Market Share by Region (2019-2030)

3 Global Gastrointestinal by Company

3.1 Global Gastrointestinal Revenue by Company (2019-2024)

3.2 Global Gastrointestinal Revenue Share by Company (2019-2024)

3.3 Competitive Landscape

3.3.1 Key Gastrointestinal Companies around the World: Ranking by Revenue

3.3.2 Global Gastrointestinal Market Concentration Ratio (CR5 and HHI) & (2019-2024)

3.3.3 Global Gastrointestinal Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.4 Global Gastrointestinal Companies Headquarters & Product Type

3.4.1 Gastrointestinal Companies Headquarters

3.4.2 Global Gastrointestinal Companies Product & Service

3.4.3 Date of International Companies Enter into Gastrointestinal Market

3.5 Global Gastrointestinal Mergers & Acquisitions, Expansion Plans

4 Company Profiles

4.1 AstraZenec

4.1.1 AstraZenec Company Information

4.1.2 AstraZenec Description, Business Overview

4.1.3 AstraZenec Gastrointestinal Products Offered

4.1.4 AstraZenec Gastrointestinal Revenue and Gross Margin (2019-2024)

4.1.5 AstraZenec Gastrointestinal Revenue by Product in 2023

4.1.6 AstraZenec Gastrointestinal Revenue by Application in 2023

4.1.7 AstraZenec Gastrointestinal Revenue by Geographic Area in 2023

4.1.8 AstraZenec Recent Developments

4.2 Sanofi

4.2.1 Sanofi Company Information

4.2.2 Sanofi Description, Business Overview

4.2.3 Sanofi Gastrointestinal Products Offered

4.2.4 Sanofi Gastrointestinal Revenue and Gross Margin (2019-2024)

4.2.5 Sanofi Gastrointestinal Revenue by Product in 2023

4.2.6 Sanofi Gastrointestinal Revenue by Application in 2023

4.2.7 Sanofi Gastrointestinal Revenue by Geographic Area in 2023

4.2.8 Sanofi Recent Developments

4.3 Bayer

4.3.1 Bayer Company Information

4.3.2 Bayer Description, Business Overview

4.3.3 Bayer Gastrointestinal Products Offered

4.3.4 Bayer Gastrointestinal Revenue and Gross Margin (2019-2024)

4.3.5 Bayer Gastrointestinal Revenue by Product in 2023

4.3.6 Bayer Gastrointestinal Revenue by Application in 2023

4.3.7 Bayer Gastrointestinal Revenue by Geographic Area in 2023

4.3.8 Bayer Recent Developments

4.4 Pfizer

4.4.1 Pfizer Company Information

4.4.2 Pfizer Description, Business Overview

4.4.3 Pfizer Gastrointestinal Products Offered

4.4.4 Pfizer Gastrointestinal Revenue and Gross Margin (2019-2024)

4.4.5 Pfizer Gastrointestinal Revenue by Product in 2023

4.4.6 Pfizer Gastrointestinal Revenue by Application in 2023

4.4.7 Pfizer Gastrointestinal Revenue by Geographic Area in 2023

4.4.8 Pfizer Recent Developments

4.5 GlaxoSmithKline

4.5.1 GlaxoSmithKline Company Information

4.5.2 GlaxoSmithKline Description, Business Overview

4.5.3 GlaxoSmithKline Gastrointestinal Products Offered

4.5.4 GlaxoSmithKline Gastrointestinal Revenue and Gross Margin (2019-2024)

4.5.5 GlaxoSmithKline Gastrointestinal Revenue by Product in 2023

4.5.6 GlaxoSmithKline Gastrointestinal Revenue by Application in 2023

4.5.7 GlaxoSmithKline Gastrointestinal Revenue by Geographic Area in 2023

4.5.8 GlaxoSmithKline Recent Developments

4.6 Teva

4.6.1 Teva Company Information

4.6.2 Teva Description, Business Overview

4.6.3 Teva Gastrointestinal Products Offered

4.6.4 Teva Gastrointestinal Revenue and Gross Margin (2019-2024)

4.6.5 Teva Gastrointestinal Revenue by Product in 2023

4.6.6 Teva Gastrointestinal Revenue by Application in 2023

4.6.7 Teva Gastrointestinal Revenue by Geographic Area in 2023

4.6.8 Teva Recent Development

4.7 Zeria（Tillotts）

4.7.1 Zeria（Tillotts） Company Information

4.7.2 Zeria（Tillotts） Description, Business Overview

4.7.3 Zeria（Tillotts） Gastrointestinal Products Offered

4.7.4 Zeria（Tillotts） Gastrointestinal Revenue and Gross Margin (2019-2024)

4.7.5 Zeria（Tillotts） Gastrointestinal Revenue by Product in 2023

4.7.6 Zeria（Tillotts） Gastrointestinal Revenue by Application in 2023

4.7.7 Zeria（Tillotts） Gastrointestinal Revenue by Geographic Area in 2023

4.7.8 Zeria（Tillotts） Recent Development

4.8 Perrigo

4.8.1 Perrigo Company Information

4.8.2 Perrigo Description, Business Overview

4.8.3 Perrigo Gastrointestinal Products Offered

4.8.4 Perrigo Gastrointestinal Revenue and Gross Margin (2019-2024)

4.8.5 Perrigo Gastrointestinal Revenue by Product in 2023

4.8.6 Perrigo Gastrointestinal Revenue by Application in 2023

4.8.7 Perrigo Gastrointestinal Revenue by Geographic Area in 2023

4.8.8 Perrigo Recent Development

4.9 Boehringer Ingelheim

4.9.1 Boehringer Ingelheim Company Information

4.9.2 Boehringer Ingelheim Description, Business Overview

4.9.3 Boehringer Ingelheim Gastrointestinal Products Offered

4.9.4 Boehringer Ingelheim Gastrointestinal Revenue and Gross Margin (2019-2024)

4.9.5 Boehringer Ingelheim Gastrointestinal Revenue by Product in 2023

4.9.6 Boehringer Ingelheim Gastrointestinal Revenue by Application in 2023

4.9.7 Boehringer Ingelheim Gastrointestinal Revenue by Geographic Area in 2023

4.9.8 Boehringer Ingelheim Recent Development

4.10 Purdue Pharma

4.10.1 Purdue Pharma Company Information

4.10.2 Purdue Pharma Description, Business Overview

4.10.3 Purdue Pharma Gastrointestinal Products Offered

4.10.4 Purdue Pharma Gastrointestinal Revenue and Gross Margin (2019-2024)

4.10.5 Purdue Pharma Gastrointestinal Revenue by Product in 2023

4.10.6 Purdue Pharma Gastrointestinal Revenue by Application in 2023

4.10.7 Purdue Pharma Gastrointestinal Revenue by Geographic Area in 2023

4.10.8 Purdue Pharma Recent Development

4.11 C.B. Fleet

4.11.1 C.B. Fleet Company Information

4.11.2 C.B. Fleet Description, Business Overview

4.11.3 C.B. Fleet Gastrointestinal Products Offered

4.11.4 C.B. Fleet Gastrointestinal Revenue and Gross Margin (2019-2024)

4.11.5 C.B. Fleet Gastrointestinal Revenue by Product in 2023

4.11.6 C.B. Fleet Gastrointestinal Revenue by Application in 2023

4.11.7 C.B. Fleet Gastrointestinal Revenue by Geographic Area in 2023

4.11.8 C.B. Fleet Recent Development

4.12 Abbott

4.12.1 Abbott Company Information

4.12.2 Abbott Description, Business Overview

4.12.3 Abbott Gastrointestinal Products Offered

4.12.4 Abbott Gastrointestinal Revenue and Gross Margin (2019-2024)

4.12.5 Abbott Gastrointestinal Revenue by Product in 2023

4.12.6 Abbott Gastrointestinal Revenue by Application in 2023

4.12.7 Abbott Gastrointestinal Revenue by Geographic Area in 2023

4.12.8 Abbott Recent Development

4.13 Jiangzhong

4.13.1 Jiangzhong Company Information

4.13.2 Jiangzhong Description, Business Overview

4.13.3 Jiangzhong Gastrointestinal Products Offered

4.13.4 Jiangzhong Gastrointestinal Revenue and Gross Margin (2019-2024)

4.13.5 Jiangzhong Gastrointestinal Revenue by Product in 2023

4.13.6 Jiangzhong Gastrointestinal Revenue by Application in 2023

4.13.7 Jiangzhong Gastrointestinal Revenue by Geographic Area in 2023

4.13.8 Jiangzhong Recent Development

4.14 Xian-Janssen

4.14.1 Xian-Janssen Company Information

4.14.2 Xian-Janssen Description, Business Overview

4.14.3 Xian-Janssen Gastrointestinal Products Offered

4.14.4 Xian-Janssen Gastrointestinal Revenue and Gross Margin (2019-2024)

4.14.5 Xian-Janssen Gastrointestinal Revenue by Product in 2023

4.14.6 Xian-Janssen Gastrointestinal Revenue by Application in 2023

4.14.7 Xian-Janssen Gastrointestinal Revenue by Geographic Area in 2023

4.14.8 Xian-Janssen Recent Development

5 Breakdown Data by Type

5.1 Global Gastrointestinal Revenue by Type (2019-2024)

5.2 Global Gastrointestinal Revenue Forecast by Type (2025-2030)

5.3 Gastrointestinal Revenue Market Share by Type (2019-2030)

6 Breakdown Data by Application

6.1 Global Gastrointestinal Revenue by Application (2019-2024)

6.2 Global Gastrointestinal Revenue Forecast by Application (2025-2030)

6.3 Gastrointestinal Revenue Market Share by Application (2019-2030)

7 North America

7.1 North America Gastrointestinal Market Size YoY Growth 2019-2030

7.2 North America Gastrointestinal Market Facts & Figures by Country (2019-2030)

7.3 North America Gastrointestinal Revenue by Type (2019-2024)

7.4 North America Gastrointestinal Revenue by Application (2019-2024)

8 Asia-Pacific

8.1 Asia-Pacific Gastrointestinal Market Size YoY Growth 2019-2030

8.2 Asia-Pacific Gastrointestinal Market Facts & Figures by Region (2019-2030)

8.3 Asia-Pacific Gastrointestinal Revenue by Type (2019-2024)

8.4 Asia-Pacific Gastrointestinal Revenue by Application (2019-2024)

9 Europe

9.1 Europe Gastrointestinal Market Size YoY Growth 2019-2030

9.2 Europe Gastrointestinal Market Facts & Figures by Country (2019-2030)

9.3 Europe Gastrointestinal Revenue by Type (2019-2024)

9.4 Europe Gastrointestinal Revenue by Application (2019-2024)

10 Latin America

10.1 Latin America Gastrointestinal Market Size YoY Growth 2019-2030

10.2 Latin America Gastrointestinal Market Facts & Figures by Country (2019-2030)

10.3 Latin America Gastrointestinal Revenue by Type (2019-2024)

10.4 Latin America Gastrointestinal Revenue by Application (2019-2024)

11 Middle East and Africa

11.1 Middle East and Africa Gastrointestinal Market Size YoY Growth 2019-2030

11.2 Middle East and Africa Gastrointestinal Market Facts & Figures by Country (2019-2030)

11.3 Middle East and Africa Gastrointestinal Revenue by Type (2019-2024)

11.4 Middle East and Africa Gastrointestinal Revenue by Application (2019-2024)

12 Supply Chain and Sales Channel Analysis

12.1 Gastrointestinal Supply Chain Analysis

12.2 Gastrointestinal Key Raw Materials and Upstream Suppliers

12.3 Gastrointestinal Clients Analysis

12.4 Gastrointestinal Sales Channel and Sales Model Analysis

12.4.1 Gastrointestinal Distribution Channel Analysis: Indirect Sales VS Direct Sales

12.4.2 Gastrointestinal Distribution Channel Analysis: Online Sales VS Offline Sales

12.4.3 Gastrointestinal Distributors

13 Market Dynamics

13.1 Gastrointestinal Industry Trends

13.2 Gastrointestinal Market Drivers

13.3 Gastrointestinal Market Challenges

13.4 Gastrointestinal Market Restraints

14 Research Findings and Conclusion

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

AstraZenec

Sanofi

Bayer

Pfizer Inc

Zeria（Tillotts）

Perrigo

Boehringer Ingelheim

Purdue Pharma

C.B. Fleet

Abbott

Jiangzhong

Xian Janssen

GlaxoSmithKline

GlaxoSmithKline PLC

TEVA

List of Tables

Table 1. Global Gastrointestinal Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Major Companies of Prescription Gastrointestinal Drug

Table 3. Major Companies of OTC Gastrointestinal Drug

Table 4. Global Gastrointestinal Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Gastrointestinal Market Size by Region (US$ Million): 2023 VS 2030

Table 6. Global Gastrointestinal Revenue by Region (2019-2024) & (US$ Million)

Table 7. Global Gastrointestinal Revenue Forecast by Region (2025-2030) & (US$ Million)

Table 8. Gastrointestinal Revenue by Company (2019-2024) & (US$ Million)

Table 9. Gastrointestinal Revenue Share by Company (2019-2024)

Table 10. Ranking of Global Top Gastrointestinal Players by Revenue (US$ Million) in 2023

Table 11. Global Gastrointestinal Companies Market Concentration Ratio (CR5 and HHI) & (2019-2024)

Table 12. Global Gastrointestinal by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gastrointestinal as of 2023)

Table 13. Global Gastrointestinal Companies Headquarters

Table 14. Global Gastrointestinal Companies Product & Service

Table 15. Date of International Companies Enter into Gastrointestinal Market

Table 16. Global Gastrointestinal Mergers & Acquisitions, Expansion Plans

Table 17. AstraZenec Company Information

Table 18. AstraZenec Description and Business Overview

Table 19. AstraZenec Gastrointestinal Product

Table 20. AstraZenec Gastrointestinal Revenue (US$ Million) and Gross Margin (2019-2024)

Table 21. AstraZenec Revenue Proportion of Gastrointestinal by Product in 2023

Table 22. AstraZenec Revenue Proportion of Gastrointestinal by Application in 2023

Table 23. AstraZenec Revenue Proportion of Gastrointestinal by Geographic Area in 2023

Table 24. AstraZenec Recent Development

Table 25. Sanofi Company Information

Table 26. Sanofi Description and Business Overview

Table 27. Sanofi Gastrointestinal Product

Table 28. Sanofi Gastrointestinal Revenue (US$ Million) and Gross Margin (2019-2024)

Table 29. Sanofi Revenue Proportion of Gastrointestinal by Product in 2023

Table 30. Sanofi Revenue Proportion of Gastrointestinal by Application in 2023

Table 31. Sanofi Revenue Proportion of Gastrointestinal by Geographic Area in 2023

Table 32. Sanofi Recent Development

Table 33. Bayer Company Information

Table 34. Bayer Description and Business Overview

Table 35. Bayer Gastrointestinal Product

Table 36. Bayer Gastrointestinal Revenue (US$ Million) and Gross Margin (2019-2024)

Table 37. Bayer Revenue Proportion of Gastrointestinal by Product in 2023

Table 38. Bayer Revenue Proportion of Gastrointestinal by Application in 2023

Table 39. Bayer Revenue Proportion of Gastrointestinal by Geographic Area in 2023

Table 40. Bayer Recent Development

Table 41. Pfizer Company Information

Table 42. Pfizer Description and Business Overview

Table 43. Pfizer Gastrointestinal Product

Table 44. Pfizer Gastrointestinal Revenue (US$ Million) and Gross Margin (2019-2024)

Table 45. Pfizer Revenue Proportion of Gastrointestinal by Product in 2023

Table 46. Pfizer Revenue Proportion of Gastrointestinal by Application in 2023

Table 47. Pfizer Revenue Proportion of Gastrointestinal by Geographic Area in 2023

Table 48. Pfizer Recent Development

Table 49. GlaxoSmithKline Company Information

Table 50. GlaxoSmithKline Description and Business Overview

Table 51. GlaxoSmithKline Gastrointestinal Product

Table 52. GlaxoSmithKline Gastrointestinal Revenue (US$ Million) and Gross Margin (2019-2024)

Table 53. GlaxoSmithKline Revenue Proportion of Gastrointestinal by Product in 2023

Table 54. GlaxoSmithKline Revenue Proportion of Gastrointestinal by Application in 2023

Table 55. GlaxoSmithKline Revenue Proportion of Gastrointestinal by Geographic Area in 2023

Table 56. GlaxoSmithKline Recent Development

Table 57. Teva Company Information

Table 58. Teva Description and Business Overview

Table 59. Teva Gastrointestinal Product

Table 60. Teva Gastrointestinal Revenue (US$ Million) and Gross Margin (2019-2024)

Table 61. Teva Revenue Proportion of Gastrointestinal by Product in 2023

Table 62. Teva Revenue Proportion of Gastrointestinal by Application in 2023

Table 63. Teva Revenue Proportion of Gastrointestinal by Geographic Area in 2023

Table 64. Teva Recent Development

Table 65. Zeria（Tillotts） Company Information

Table 66. Zeria（Tillotts） Description and Business Overview

Table 67. Zeria（Tillotts） Gastrointestinal Product

Table 68. Zeria（Tillotts） Gastrointestinal Revenue (US$ Million) and Gross Margin (2019-2024)

Table 69. Zeria（Tillotts） Revenue Proportion of Gastrointestinal by Product in 2023

Table 70. Zeria（Tillotts） Revenue Proportion of Gastrointestinal by Application in 2023

Table 71. Zeria（Tillotts） Revenue Proportion of Gastrointestinal by Geographic Area in 2023

Table 72. Zeria（Tillotts） Recent Development

Table 73. Perrigo Company Information

Table 74. Perrigo Description and Business Overview

Table 75. Perrigo Gastrointestinal Product

Table 76. Perrigo Gastrointestinal Revenue (US$ Million) and Gross Margin (2019-2024)

Table 77. Perrigo Revenue Proportion of Gastrointestinal by Product in 2023

Table 78. Perrigo Revenue Proportion of Gastrointestinal by Application in 2023

Table 79. Perrigo Revenue Proportion of Gastrointestinal by Geographic Area in 2023

Table 80. Perrigo Recent Development

Table 81. Boehringer Ingelheim Company Information

Table 82. Boehringer Ingelheim Description and Business Overview

Table 83. Boehringer Ingelheim Gastrointestinal Product

Table 84. Boehringer Ingelheim Gastrointestinal Revenue (US$ Million) and Gross Margin (2019-2024)

Table 85. Boehringer Ingelheim Revenue Proportion of Gastrointestinal by Product in 2023

Table 86. Boehringer Ingelheim Revenue Proportion of Gastrointestinal by Application in 2023

Table 87. Boehringer Ingelheim Revenue Proportion of Gastrointestinal by Geographic Area in 2023

Table 88. Boehringer Ingelheim Recent Development

Table 89. Purdue Pharma Company Information

Table 90. Purdue Pharma Description and Business Overview

Table 91. Purdue Pharma Gastrointestinal Product

Table 92. Purdue Pharma Gastrointestinal Revenue (US$ Million) and Gross Margin (2019-2024)

Table 93. Purdue Pharma Revenue Proportion of Gastrointestinal by Product in 2023

Table 94. Purdue Pharma Revenue Proportion of Gastrointestinal by Application in 2023

Table 95. Purdue Pharma Revenue Proportion of Gastrointestinal by Geographic Area in 2023

Table 96. Purdue Pharma Recent Development

Table 97. C.B. Fleet Company Information

Table 98. C.B. Fleet Description and Business Overview

Table 99. C.B. Fleet Gastrointestinal Product

Table 100. C.B. Fleet Gastrointestinal Revenue (US$ Million) and Gross Margin (2019-2024)

Table 101. C.B. Fleet Revenue Proportion of Gastrointestinal by Product in 2023

Table 102. C.B. Fleet Revenue Proportion of Gastrointestinal by Application in 2023

Table 103. C.B. Fleet Revenue Proportion of Gastrointestinal by Geographic Area in 2023

Table 104. C.B. Fleet Recent Development

Table 105. Abbott Company Information

Table 106. Abbott Description and Business Overview

Table 107. Abbott Gastrointestinal Product

Table 108. Abbott Gastrointestinal Revenue (US$ Million) and Gross Margin (2019-2024)

Table 109. Abbott Revenue Proportion of Gastrointestinal by Product in 2023

Table 110. Abbott Revenue Proportion of Gastrointestinal by Application in 2023

Table 111. Abbott Revenue Proportion of Gastrointestinal by Geographic Area in 2023

Table 112. Abbott Recent Development

Table 113. Jiangzhong Company Information

Table 114. Jiangzhong Description and Business Overview

Table 115. Jiangzhong Gastrointestinal Product

Table 116. Jiangzhong Gastrointestinal Revenue (US$ Million) and Gross Margin (2019-2024)

Table 117. Jiangzhong Revenue Proportion of Gastrointestinal by Product in 2023

Table 118. Jiangzhong Revenue Proportion of Gastrointestinal by Application in 2023

Table 119. Jiangzhong Revenue Proportion of Gastrointestinal by Geographic Area in 2023

Table 120. Jiangzhong Recent Development

Table 121. Xian-Janssen Company Information

Table 122. Xian-Janssen Description and Business Overview

Table 123. Xian-Janssen Gastrointestinal Product

Table 124. Xian-Janssen Gastrointestinal Revenue (US$ Million) and Gross Margin (2019-2024)

Table 125. Xian-Janssen Revenue Proportion of Gastrointestinal by Product in 2023

Table 126. Xian-Janssen Revenue Proportion of Gastrointestinal by Application in 2023

Table 127. Xian-Janssen Revenue Proportion of Gastrointestinal by Geographic Area in 2023

Table 128. Xian-Janssen Recent Development

Table 129. Global Gastrointestinal Revenue by Type (2019-2024) & (US$ Million)

Table 130. Global Gastrointestinal Revenue Forecast by Type (2025-2030) & (US$ Million)

Table 131. Global Gastrointestinal Revenue by Application (2019-2024) & (US$ Million)

Table 132. Global Gastrointestinal Revenue Forecast by Application (2025-2030) & (US$ Million)

Table 133. North America Gastrointestinal Revenue by Country (2019-2024) & (US$ Million)

Table 134. North America Gastrointestinal Revenue by Country (2025-2030) & (US$ Million)

Table 135. North America Gastrointestinal Revenue by Type (2019-2024) & (US$ Million)

Table 136. North America Gastrointestinal Revenue by Application (2019-2024) & (US$ Million)

Table 137. Asia-Pacific Gastrointestinal Revenue by Region (2019-2030) & (US$ Million)

Table 138. Asia-Pacific Gastrointestinal Revenue by Region (2025-2030) & (US$ Million)

Table 139. Asia-Pacific Gastrointestinal Revenue by Type (2019-2024) & (US$ Million)

Table 140. Asia-Pacific Gastrointestinal Revenue by Application (2019-2024) & (US$ Million)

Table 141. Europe Gastrointestinal Revenue by Country (2019-2024) & (US$ Million)

Table 142. Europe Gastrointestinal Revenue by Country (2025-2030) & (US$ Million)

Table 143. Europe Gastrointestinal Revenue by Type (2019-2024) & (US$ Million)

Table 144. Europe Gastrointestinal Revenue by Application (2019-2024) & (US$ Million)

Table 145. Latin America Gastrointestinal Revenue by Country (2019-2024) & (US$ Million)

Table 146. Latin America Gastrointestinal Revenue by Country (2025-2030) & (US$ Million)

Table 147. Latin America Gastrointestinal Revenue by Type (2019-2024) & (US$ Million)

Table 148. Latin America Gastrointestinal Revenue by Application (2019-2024) & (US$ Million)

Table 149. Middle East and Africa Gastrointestinal Revenue by Country (2019-2024) & (US$ Million)

Table 150. Middle East and Africa Gastrointestinal Revenue by Country (2025-2030) & (US$ Million)

Table 151. Middle East and Africa Gastrointestinal Revenue by Type (2019-2024) & (US$ Million)

Table 152. Middle East and Africa Gastrointestinal Revenue by Application (2019-2024) & (US$ Million)

Table 153. Gastrointestinal Key Raw Materials, Industry Status and Trend

Table 154. Gastrointestinal Key Raw Materials and Upstream Suppliers

Table 155. Gastrointestinal Clients Status and Trend

Table 156. Gastrointestinal Typical Clients

Table 157. Gastrointestinal Distributors

Table 158. Gastrointestinal Market Trends

Table 159. Gastrointestinal Market Drivers

Table 160. Gastrointestinal Market Challenges

Table 161. Gastrointestinal Market Restraints

Table 162. Research Programs/Design for This Report

Table 163. Key Data Information from Secondary Sources

Table 164. Key Data Information from Primary Sources

List of Figures

Figure 1. Gastrointestinal Product Picture

Figure 2. Global Gastrointestinal Revenue Market Share by Type in 2023 & 2030

Figure 3. Prescription Gastrointestinal Drug Product Picture

Figure 4. OTC Gastrointestinal Drug Product Picture

Figure 5. Global Gastrointestinal Revenue Market Share by Application in 2023 & 2030

Figure 6. Chronic Gastritis

Figure 7. Functional Dyspepsia

Figure 8. Peptic Ulcer

Figure 9. Acute Gastroenteritis

Figure 10. Others

Figure 11. Gastrointestinal Report Years Considered

Figure 12. Global Gastrointestinal Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Gastrointestinal Market Size 2019-2030 (US$ Million)

Figure 14. Global Gastrointestinal Market Size Market Share by Region: 2023 Versus 2030

Figure 15. Global Gastrointestinal Revenue Market Share by Region (2019-2030)

Figure 16. Gastrointestinal Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 17. Global Gastrointestinal Revenue Market Share Forecast by Type (2019-2030)

Figure 18. Global Gastrointestinal Revenue Market Share Forecast by Application (2019-2030)

Figure 19. North America Gastrointestinal Revenue 2019-2030 (US$ Million)

Figure 20. North America Gastrointestinal Revenue Market Share by Type (2019-2024)

Figure 21. North America Gastrointestinal Revenue Market Share by Application (2019-2024)

Figure 22. Asia-Pacific Gastrointestinal Revenue 2019-2030 (US$ Million)

Figure 23. Asia-Pacific Gastrointestinal Revenue Market Share by Region (2019-2030)

Figure 24. Asia-Pacific Gastrointestinal Revenue Market Share by Type (2019-2024)

Figure 25. Asia-Pacific Gastrointestinal Revenue Market Share by Application (2019-2024)

Figure 26. Europe Gastrointestinal Revenue Growth Rate 2019-2030 (US$ Million)

Figure 27. Europe Gastrointestinal Revenue Market Share by Country (2019-2030)

Figure 28. Europe Gastrointestinal Revenue Market Share by Type (2019-2024)

Figure 29. Europe Gastrointestinal Revenue Market Share by Application (2019-2024)

Figure 30. Latin America Gastrointestinal Revenue Growth Rate 2019-2030 (US$ Million)

Figure 31. Latin America Gastrointestinal Revenue Market Share by Country (2019-2024)

Figure 32. Latin America Gastrointestinal Revenue Market Share by Type (2019-2024)

Figure 33. Latin America Gastrointestinal Revenue Market Share by Application (2019-2024)

Figure 34. Middle East and Africa Gastrointestinal Revenue Growth Rate 2019-2030 (US$ Million)

Figure 35. Middle East and Africa Gastrointestinal Revenue Market Share by Country (2019-2030)

Figure 36. Middle East and Africa Gastrointestinal Revenue Market Share by Type (2019-2024)

Figure 37. Middle East and Africa Gastrointestinal Revenue Market Share by Application (2019-2024)

Figure 38. Gastrointestinal Supply Chain (Upstream and Downstream Market)

Figure 39. Global Production Market Share of Gastrointestinal Raw Materials by Region in 2023

Figure 40. Gastrointestinal Distribution Channels

Figure 41. Global Gastrointestinal Percentage 2019-2030: Indirect Sales VS Direct Sales

Figure 42. Global Gastrointestinal Percentage 2019-2030: Online Sales VS Offline Sales

Figure 43. Bottom-up and Top-down Approaches for This Report

Figure 44. Data Triangulation

Figure 45. Key Executives Interviewed

Figure 46. Global Gastrointestinal Percentage 2019-2030: Online Sales VS Offline Sales

Figure 47. Bottom-up and Top-down Approaches for This Report

Figure 48. Data Triangulation

Figure 49. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$5900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global HFCWO Vest Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-6I14576

Thu Jul 25 00:00:00 UTC 2024

Add to Cart

Global Tumor Diagnosis Solutions Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-21H12722

Thu Jul 25 00:00:00 UTC 2024

Add to Cart

Global SGLT2 Inhibitors Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-25F12438

Thu Jul 25 00:00:00 UTC 2024

Add to Cart

Global Hepatitis A immunoglobulin Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-17D12859

Thu Jul 25 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions